Search

Your search keyword '"OVERALL survival"' showing total 5 results
5 results on '"OVERALL survival"'

Search Results

1. Survival Outcomes and PROs Favor Cemiplimab + Chemotherapy vs Chemotherapy Alone in Advanced NSCLC Regardless of PD-L1 Status.

2. Induction Chemotherapy Prior to Chemoradiation Represents Potential New SOC in Locally Advanced Cervical Cancer.

3. Clinical Updates: PROSTATE CANCER. Darolutamide delays time to progression from mHSPC to mCRPC vs placebo.

4. Clinical Updates: PROSTATE CANCER. Survival may be improving in de novo mHSPC, new data suggest.

5. Pembrolizumab/axitinib sustains efficacy in ccRCC at 5-year follow-up.

Catalog

Books, media, physical & digital resources